Source link : https://www.newshealth.biz/health-news/pause-or-keep-ras-inhibitors-before-surgery-take-your-pick/
LONDON — No blanket statement could be made regarding whether patients undergoing noncardiac surgery should continue or withdraw their renin-angiotensin system (RAS) inhibitor therapy based on the Stop-or-Not Trial. Death and major complications at 28 days after surgery came out to the same 22% rate between continuation and discontinuation strategies (RR 1.02, 95% CI 0.87-1.19). […]
Author : News Health
Publish date : 2024-08-31 13:38:36
Copyright for syndicated content belongs to the linked Source.